好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cognitive Effects of Extended-Release Once-Daily SPN-538 (Trokendi XR™) vs b.i.d. Immediate-Release Topiramate (TPM-IR, Topamax®) in Healthy Volunteers
Epilepsy/Clinical Neurophysiology (EEG)
(-)
002
Authors/Disclosures
Janet Johnson
PRESENTER
No disclosure on file
Scott Brittain (Supernus Pharmaceuticals, Inc.) No disclosure on file
Stefan Schwabe, MD, PhD (Supernus Pharmaceuticals) No disclosure on file
John G. Whitesides John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB.